StockGlow

Lepu Biopharma Co., Ltd. (2157.HK)

Lepu Biopharma Co., Ltd., a biopharmaceutical company, focuses on the discovery, development, and commercialization of drug candidates in anti-tumor targeted therapy and oncology immunotherapy in China and internationally.

4.52-0.02%Healthcare
Compare 2157.HK with
StockGlow Score
29
Leaning Bearish
BearishBullish
1 year ago-43.1%

The outlook

Lepu Biopharma Co., Ltd. currently reads as leaning bearish based on mixed vs its moving averages, 14% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.

What’s behind the score

Price trendMixed vs its moving averages
52-week range14% of the way from its 52-week low to high
Market cap
$8.16B
52-wk high
10.50
52-wk low
3.55
50-day avg
4.20
200-day avg
5.11
Trailing P/E
26.6

Similar stocks

2171.HKCARsgen Therapeutics Holdings Limited$13.50+2.43%2162.HKKeymed Biosciences Inc.$75.25-3.59%2179.HKJiangsu Recbio Technology Co., Ltd.$5.04+0.00%2142.HKHBM Holdings Limited$12.26-1.13%2197.HKClover Biopharmaceuticals, Ltd.$1.67+1.21%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy